| Literature DB >> 35927769 |
Youlim Kim1, Hyeonkyeong Lee2, Misook Lee Chung3.
Abstract
BACKGROUND: The risk of Cardiovascular disease (CVDs) among adult populations is influenced by environmental factors, and immigrant populations tend to be more vulnerable. This study examined the effectiveness of a 24-week walking program based on social-cognitive determinants through mobile app for CVD risk reduction among female Korean-Chinese middle-aged workers.Entities:
Keywords: Cardiovascular disease; Exercise; Psychological theory; Transients and migrants; Walking
Year: 2022 PMID: 35927769 PMCID: PMC9351079 DOI: 10.1186/s13690-022-00941-z
Source DB: PubMed Journal: Arch Public Health ISSN: 0778-7367
Fig. 1The CONSORT flow diagram for RCT
Mobile-based health program
| Standard intervention | Enhanced intervention | |
|---|---|---|
• Providing Fitbit Alta device • Providing mobile app for monitoring walking steps and health information | • Providing Fitbit Alta device • Providing mobile app for monitoring walking steps and health information | |
• Self-efficacy: setting goal of walking steps, sending a medal image by SNS and, sending short 12 text messages enhancing exerciseefficacy • Social support: sharing information on exercise with participants, supporting each other exercise through SNS • Sense of community: photovoice (i.e., our neighborhood, good place to exercise) | ||
| • Walking and self monitoring based on mobile app self-walking exercise without intervention from research team | • Walking and self-monitoring based on mobile app without intervention from research team |
Participants’ sociodemographic and health-related characteristics at baseline
| ET ( | ST ( | U | |||||
|---|---|---|---|---|---|---|---|
| n (%) | Mean (SD) | n (%) | Mean (SD) | ||||
| 47.79 (7.01) | 53.27 (7.32) | 182.0 | .014 | ||||
| 9.57 (4.40) | 9.73 (5.20) | 290.0 | .729 | ||||
| 11.97 (6.27) | 13.80 (4.98) | 261.0 | .358 | ||||
| 1486.98 (481.80) | 1699.62 (573.05) | 280.0 | .197 | ||||
| ≥ high school | 19 (60.7) | 14 (63.6) | 1.322 | .610 | |||
| Married | 25 (89.3) | 22 (100.0) | 2.508 | .285 | |||
| Service | 12 (42.9) | 15 (68.2) | 4.702 | .328 | |||
| Sales | 5 (17.9) | 2 (9.1) | |||||
| Office job | 3 (10.7) | 2 (9.1) | |||||
| Self-employment | 2 (7.1) | 2 (9.1) | |||||
| Others | 6 (21.4) | 1 (4.5) | |||||
| Yes | 5 (17.9) | 8 (36.4) | 2.193 | .139 | |||
| Yes | 7 (30.4) | 13 (68.4) | 6.019 | .014 | |||
| Number of steps | 10,430.14 (3837.43) | 10,422.36 (3164.14) | 287.5 | .689 | |||
| MPA time (min/week) | 172.32 (129.90) | 175.95 (113.52) | 292.0 | .755 | |||
| Total cholesterol | 187.29 (30.73) | 192.55 (37.39) | 285.0 | .653 | |||
| LDL cholesterol | 100.61 (29.16) | 93.41 (40.16) | 271.0 | .470 | |||
| HDL cholesterol | 53.68 (12.59) | 58.64 (19.50) | 271.5 | .475 | |||
| Triglycerides | 148.93 (73.06) | 166.23 (63.19) | 236.5 | .162 | |||
| Fasting blood sugar | 94.26 (10.76) | 96.05 (19.99) | 270.5 | .463 | |||
| 1.41 (1.23) | 2.42 (2.10) | 237.0 | .164 | ||||
ET Enhanced treatment, ST Standard treatment, SD Standard deviation, MPA Moderate-intensity physical activity, ASCVD Atherosclerotic cardiovascular disease
Comparison of changes in physical activity between the two groups
| Variables | B / OR | SE | |
|---|---|---|---|
| Week 12 | −.762 | .321 | .018 |
| Week 24 | −.171 | .711 | .810 |
| ET | −.178 | 1.192 | .882 |
| ET a Week 12 | 1.563 | .422 | <.001 |
| ET a Week 24 | 1.295 | .950 | .173 |
| Week 12 | −.672 | .696 | .511 |
| Week 24 | −.372 | .809 | .646 |
| ET | −.105 | .687 | .878 |
| ET a Week 12 | 6.396 | .854 | .030 |
| ET a Week 24 | 5.965 | .931 | .055 |
The model was adjusted for age and menopausal status
aindicates interaction of group and time
SE Standard error, ET Enhanced treatment, ST Standard treatment, MPA Moderate-intensity physical activity, OR Odds ratio
Comparison of changes in health outcomes between two groups
| Variables | B | SE | |
|---|---|---|---|
| Week 12 | −.160 | 3.203 | .960 |
| Week 24 | 3.263 | 3.034 | .282 |
| ET | −4.747 | 6.003 | .429 |
| ET a Week 12 | 10.522 | 3.914 | .007 |
| ET a Week 24 | 7.215 | 4.251 | .090 |
| Week 12 | 5.961 | 5.132 | .245 |
| Week 24 | 9.684 | 6.136 | .114 |
| ET | 2.211 | 10.529 | .834 |
| ET a Week 12 | −16.178 | 7.161 | .024 |
| ET a Week 24 | −4.38 | 9.854 | .657 |
| Week 12 | −23.262 | 23.253 | .317 |
| Week 24 | −28.105 | 19.477 | .149 |
| ET | −20.518 | 23.415 | .381 |
| ET a Week 12 | 36.212 | 30.944 | .242 |
| ET a Week 24 | 17.915 | 26.320 | .495 |
| Week 12 | −.262 | 4.232 | .951 |
| Week 24 | 2.737 | 6.874 | .691 |
| ET | 5.933 | 11.385 | .602 |
| ET a Week 12 | −20.325 | 9.837 | .039 |
| ET a Week 24 | −20.911 | 10.289 | .059 |
| Week 12 | 4.112 | 3.295 | 0.212 |
| Week 24 | −2.368 | 2.579 | 0.358 |
| ET | −1.117 | 4.127 | 0.787 |
| ET a Week 12 | −8.138 | 4.069 | 0.046 |
| ET a Week 24 | −1.805 | 3.485 | 0.604 |
| Week 12 | −0.080 | 0.056 | .155 |
| Week 24 | −0.343 | 0.265 | .195 |
| ET | −0.200 | 0.484 | .679 |
| ET a Week 12 | −0.521 | 0.076 | <.001 |
| ET a Week 24 | −0.010 | 0.345 | .976 |
The model was adjusted for age and menopausal status
aindicates interaction of group and time
SE Standard error, ASCVD,Atherosclerotic cardiovascular disease, ET Enhanced treatment, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, TC Total cholesterol, FBS Fasting blood sugar